Ken M. serves as the Head of Clinical Quality Assurance at Cytokinetics, overseeing CQA management encompassing GCP, PV, and GCLP since June 2023. Previously, Ken held the position of Director of GCP Quality Assurance at Exelixis from April 2018 to June 2023, contributing to GCP QA oversight and management, while also serving as Associate Director in the same domain. Prior experience includes a role as Senior Manager of Clinical Quality Assurance at Theravance Biopharma US, Inc., along with positions in Clinical Quality Management at Medivation. Ken's career began in Clinical Trial Management at Roche and GenturaDx, and earlier, Ken worked as a Researcher at Arcadia Biosciences. Ken earned a Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Davis, and a Master of Science in Medical Product Development Management from San José State University.
This person is not in any teams
This person is not in any offices